Abstract
The phosphorylation of glucose by human erythrocyte hexokinase follows classical Michaelis-Menten kinetics; hexokinase manifests maximum activity at 5 mM glucose, and no further increase in activity can be measured at higher glucose concentrations. However, the erythrocytes of diabetics and normal erythrocytes incubated with high concentrations of glucose contain increased concentrations of glucose 6-phosphate. To elucidate the mechanism of accumulation of glucose 6-phosphate when erythrocytes are exposed to high glucose concentrations, hexokinase activity was examined in the presence of naturally occurring inhibitors, such as glucose 1,6-bisphosphate, 2,3-diphosphoglycerate, ADP, and glucose 6-phosphate at physiological concentrations. Without inhibitors or in the presence of glucose 1,6-bisphosphate,2,3-diphosphoglycerate, and ADP, maximum hexokinase activity was observed at 5 mM glucose concentration. On the contrary, in the presence of glucose 6-phosphate, hexokinase activity increased at glucose concentrations greater than 5 mM; inhibition by glucose 6-phosphate was partially competitive with glucose. The relief by glucose of glucose 6-phosphate inhibition of hexokinase is a possible explanation of the increased glucose 6-phosphate level in diabetic erythrocytes.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beutler E. 2,3-diphosphoglycerate affects enzymes of glucose metabolism in red blood cells. Nat New Biol. 1971 Jul 7;232(27):20–21. doi: 10.1038/newbio232020a0. [DOI] [PubMed] [Google Scholar]
- Beutler E., West C., Blume K. G. The removal of leukocytes and platelets from whole blood. J Lab Clin Med. 1976 Aug;88(2):328–333. [PubMed] [Google Scholar]
- Brewer G. J. Erythrocyte metabolism and function: hexokinase inhibition by 2,3-diphosphogly- cerate and interaction with ATP and Mg2+. Biochim Biophys Acta. 1969 Nov 18;192(2):157–161. doi: 10.1016/0304-4165(69)90350-x. [DOI] [PubMed] [Google Scholar]
- Gerber G., Preissler H., Heinrich R., Rapoport S. M. Hexokinase of human erythrocytes. Purification, kinetic model and its application to the conditions in the cell. Eur J Biochem. 1974 Jun 1;45(1):39–52. doi: 10.1111/j.1432-1033.1974.tb03527.x. [DOI] [PubMed] [Google Scholar]
- Kono N., Kuwajima M., Tarui S. Alteration of glycolytic intermediary metabolism in erythrocytes during diabetic ketoacidosis and its recovery phase. Diabetes. 1981 Apr;30(4):346–353. doi: 10.2337/diab.30.4.346. [DOI] [PubMed] [Google Scholar]
- McDonald M. J., Shapiro R., Bleichman M., Solway J., Bunn H. F. Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. J Biol Chem. 1978 Apr 10;253(7):2327–2332. [PubMed] [Google Scholar]
- Rijksen G., Staal G. E. Purification and some properties of human erythrocyte hexokinase. Biochim Biophys Acta. 1976 Sep 14;445(2):330–341. doi: 10.1016/0005-2744(76)90087-5. [DOI] [PubMed] [Google Scholar]
- Rijksen G., Staal G. E. Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate. Biochim Biophys Acta. 1977 Nov 23;485(1):75–86. doi: 10.1016/0005-2744(77)90194-2. [DOI] [PubMed] [Google Scholar]
- Stevens V. J., Vlassara H., Abati A., Cerami A. Nonenzymatic glycosylation of hemoglobin. J Biol Chem. 1977 May 10;252(9):2998–3002. [PubMed] [Google Scholar]
- Tegos C., Beutler E. Red cell glycolytic intermediates in diabetic patients. J Lab Clin Med. 1980 Jul;96(1):85–89. [PubMed] [Google Scholar]